Thank you for visiting us
We are excited to share current and upcoming clinical trials
Panic Disorder Studies
We are looking for adult people living in the United States to complete brief questionnaires and participate in a 60 to 90 minute interview. If you qualify for this study and complete questionnaires and the interview, you would be compensated $125.
Balance-AAD-1-Study
https://clinicaltrials.gov/study/NCT06808984
Pediatric Autism Studies
The 601/602 Pediatric Autism Study is looking at an investigational study drug for children and teenagers with a diagnosis of autism spectrum disorder. We are currently looking to recruit autistic teenagers 13–17 years of age, who are experiencing irritability, which can be expressed as tantrums, aggression, yelling, or self-harming behavior. To learn whether your child might be eligible, please contact us: 909-955-5865 or research@inlandpsych.com.
For more information about participating in this study at IPMG – click here
Depression Studies
For more information about Biohaven research study at IPMG – Click Here
Vanda Pharmaceuticals Inc
Depression Research Study
Is your antidepressent not enough? You may qualify for a clinical research study testing an investigational add-on treatment for adults with Major Depressive Disorder (MDD).
Study-related care and medication at no cost
Compensation for time and travel
Weekly study visits
Now Enrolling
Eligibility
✓ Anyone 18 to 65 years of age
✔ Diagnosis of Major Depressive Disorder
✓ Are currently taking an antidepressant
✔Are still experiencing symptoms
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
AMPA-Vega 2 Study
This study is researching an investigational drug to see if it is safe and whether it improves symptoms of MDD when taken with your current antidepressant medication(s).
Participation in the study may last about 3 years and includes 42 study site visits. All participants will be able to remain on their current antidepressant edication(s) while taking part. Reimbursement may be available for applicable travel costs and
inconveniences.
TO PARTICIPATE IN THIS STUDY, YOU MUST:
✓ Be at least 18 years old
✔ Have a primary diagnosis of MDD
✓ Be currently receiving at least 1 antidepressant medication
✔Have had inadequate response to up to 5 oral antidepressant medications
✔Not be pregnant, breastfeeding, or planning to become pregnant during the study
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
Alto
The PACE-1 Study is examining a potential new treatment option for people with
depression who haven’t responded to their current medication. If you’re taking
antidepressants but aren’t feeling relief, this study may be for you.
WHO CAN JOIN?
To join you must
✓ Be 18-75 years of age
✔ Not be pregnant, planning to become pregnant, or breastfeeding
✓Have a prior diagnosis of major depressivedisorder(MDD)
✔Be currently taking antidepressants
Axsome
Major depressive disorder with excessive daytime sleepiness. Clinical research study now enrolling.
WHO CAN JOIN?
To join you must
✓ Be 18-75 years of age
✔ Not be pregnant, planning to become pregnant, or breastfeeding
✓Have a prior diagnosis of major depressive disorder(MDD)
✔Be currently taking antidepressants
Cybin
This Phase 3 clinical trial is evaluating an investigational,
2-dose-treatment (yes, not a daily pill!) for adults diagnosed with Major Depressive Disorder. The treatment is not taken every day.Â
 This study is designed to assess effectiveness (versus daily, twice-daily, or three-times-daily treatments). Participation lasts several months and includes both in-person and remote visits. In order to qualify for the study, your depression needs to be actually diagnosed, but does not need to be directly related to a specific event from your service.
If you’re living with Major Depressive Disorder (MDD), you’re not weak, and you’re not alone. Many of us who’ve served understand this firsthand. That’s why a veteran-led recruitment team is partnering with a pharmaceutical company committed to helping, offering service members, veterans, and law enforcement professionals the opportunity to participate in a clinical research study evaluating a new treatment designed specifically for us.
Depression Studies
For more information about Ventura-5 research study at IPMG – Click Here
ITI Pediatric Bipolar 1 and 2 Depressive Episode
Are you interested in an investigational study drug for teenagers with bipolar depression? We are looking for study volunteers between 13 and 17 years of age who have been diagnosed with bipolar disorder and are currently experiencing a major depressive episode. To learn whether you, or someone you know, might be eligible, please visit our website to fill out our forms: Click Here
You can also call us (909) 955-5865 or use our Virtual Waiting Room to talk/chat or video call one of our Clinical Research Coordinators Virtual Waiting Room
ALTO-100-211 Study
The Balance Study
If you or your child have bipolar I depression, we are inviting you to take part in the Balance Study for children and teens, aged 10 to 17 years old, who have been struggling with bipolar I depression. The purpose of this study is to evaluate the safety and efficacy of an investigational drug for bipolar I depression in children and teens.
The Balance Study will enroll about 338 children and teens with bipolar I depression at participating study centers throughout North America.
Who can take part in the Balance Study?
You or your child may be eligible to join the Balance Study if you or they:
- Are 10 to 17 years old
- Have a diagnosis of bipolar I disorder
- Are currently experiencing an episode of depression:
- Symptoms of depression include feeling sad, down, or depressed, not enjoying things you usually do, suicidal thoughts, difficulty falling or staying asleep, loss of energy, difficulty concentrating
There is no cost to participate in the study. Patients who take part will receive all
study-related visits, tests, and investigational drug from a dedicated medical team at
no cost. No health insurance is required.
Bipolar and Schizophrenia Study
A research study for children and teenagers with schizophrenia or Bipolar disorder.
This study is looking at how safe
a study drug is and how well it works in children and teenagers with schizophrenia or bipolar disorder.
The study drug is approved for the treatment of schizophrenia and bipolar depression in adults. However, it is not yet approved for children with schizophrenia or bipolar disorder.
The Balance Study will enroll about 338 children and teens with bipolar I depression at participating study centers throughout North America.
Does your child have schizophrenia or bipolar disorder? The 321 Study is looking for volunteers who are:
- 13-17 years of age with a diagnosis of schizophrenia
- 10-17 years of age with
a diagnosis of bipolar
I or II disorder (must have completed a prior lumateperone study).
BALSAM-3 Study
What is the BALSAM-3 Study?
The BALSAM-3 Study is a clinical study being done to learn more about the long-term safety and effectiveness of an
investigational drug called KarXT
in adults with bipolar disorder.
- Doctors and researchers want to see if KarXT can safely
manage symptoms and manic
episodes when taken for a long
period of time.
lithium, valproate, or
lamotrigine
BALSAM-4 Study
What is the BALSAM-4 Study?
The BALSAM-4 Study is a clinical study testing an investigational
drug called KarXT in adults with
bipolar disorder.
- Doctors and researchers want to see if KarXT can safely
manage symptoms and manic
episodes when taken for a long
period of time.
UPCOMING TRIALS
- Psychedelic Therapeutics
- Women’s Mental Health
- Generalized Anxiety Disorder
- Bipolar Disorder
- Schizophrenia
- Adolescent and Pediatric
- Dementia
Pediatric & Adolescent Clinical Trials
We are offering access to studies focused on discovering innovative methods for diagnosis, treatments, therapies and interventions for children with severe mental health symptoms or neurodevelopmental disorders.
Our dedicated team of researchers and physicians want to help kids with severe mental health symptoms such as Bipolar or Schizophrenia and Neurodevelopmental Disorders such as ASD and their families live happier, healthier lives.
Our Pediatric & Adolescent Research Suites are specifically designed to be a trusted place where children can feel safe and reach their true potential.
Research for children is needed to improve opportunities for those with Severe Mental Health Disorders and ASD-related neurodevelopmental issues.
At IPMG, we work with children & teens to collect firsthand data that helps us to better understand these conditions. With no two cases alike, the information gained from your child’s experience can support the development of life-changing treatments and therapies for your child and potentially for families worldwide.
It’s important for children and families to feel comfortable and safe while at their Clinical Research Visits which can include uncomfortable experiences like a blood draw.
Even adults often may find blood draws or lab draws to be anxiety provoking. We are so proud of our little ones that are brave enough to get routine blood draws and we want to ensure we provide the support needed during these visits.
Check your Child/Teens BMI
This is an important calculation needed to see if you or your child may be eligible for the particular Clinical trials.
Thank you for visiting us
We are excited to share current and upcoming clinical trials
Panic Disorder Studies
We are looking for adult people living in the United States to complete brief questionnaires and participate in a 60 to 90 minute interview. If you qualify for this study and complete questionnaires and the interview, you would be compensated $125.
For more information about participating in this non-interventional – click here
Balance-AAD-1 Study
If you or someone you know is experiencing agitation associated with Alzheimer’s disease, the BALANCE-AAD-1 Study may interest you.
The study is enrolling adults who:
* Are 55 to 90 years of age.
* Have Alzheimer’s disease.
* Have been experiencing agitation for at least 4 weeks.
Pediatric Autism Studies
The 601/602 Pediatric Autism Study is looking at an investigational study drug for children and teenagers with a diagnosis of autism spectrum disorder. We are currently looking to recruit autistic teenagers 13–17 years of age, who are experiencing irritability, which can be expressed as tantrums, aggression, yelling, or self-harming behavior. To learn whether your child might be eligible, please contact us: 909-955-5865 or research@inlandpsych.com.
Depression Studies
For more information about Biohaven research study at IPMG – Click Here
Depression Research Study –
Is your antidepressent not enough?
You may qualify for a clinical research study testing an investigational add-on treatment for adults with Major Depressive Disorder (MDD).
Study-related care and medication at no cost
Compensation for time and travel
Weekly study visits
Now Enrolling
Eligibility
✓ Anyone 18 to 65 years of age
✔ Diagnosis of Major Depressive Disorder
✓ Are currently taking an antidepressant
✔Are still experiencing symptoms
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
AMPA-Vega 2 Study
This study is researching an investigational drug to see if it is safe and whether it improves symptoms of MDD when taken with your current antidepressant medication(s).
Participation in the study may last about 3 years and includes 42 study site visits. All participants will be able to remain on their current antidepressant edication(s) while taking part. Reimbursement may be available for applicable travel costs and
inconveniences.
TO PARTICIPATE IN THIS STUDY, YOU MUST:
✓ Be at least 18 years old
✔ Have a primary diagnosis of MDD
✓ Be currently receiving at least 1 antidepressant medication
✔Have had inadequate response to up to 5 oral antidepressant medications
✔Not be pregnant, breastfeeding, or planning to become pregnant during the study
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
Alto
The PACE-1 Study is examining a potential new treatment option for people with
depression who haven’t responded to their current medication. If you’re taking
antidepressants but aren’t feeling relief, this study may be for you.
WHO CAN JOIN?
To join you must
✓ Be 18-75 years of age
✔ Not be pregnant, planning to become pregnant, or breastfeeding
✓Have a prior diagnosis of major depressivedisorder(MDD)
✔Be currently taking antidepressants
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
Axsome
Major depressive disorder with excessive daytime sleepiness. Clinical research study now enrolling.
WHO CAN JOIN?
To join you must
✓ Be 18-75 years of age
✔ Not be pregnant, planning to become pregnant, or breastfeeding
✓Have a prior diagnosis of major depressivedisorder(MDD)
✔Be currently taking antidepressants
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
Cybin
This Phase 3 clinical trial is evaluating an investigational,
2-dose-treatment (yes, not a daily pill!) for adults diagnosed with Major Depressive Disorder. The treatment is not taken every day.Â
 This study is designed to assess effectiveness (versus daily, twice-daily, or three-times-daily treatments). Participation lasts several months and includes both in-person and remote visits. In order to qualify for the study, your depression needs to be actually diagnosed, but does not need to be directly related to a specific event from your service.
If you’re living with Major Depressive Disorder (MDD), you’re not weak, and you’re not alone. Many of us who’ve served understand this firsthand. That’s why a veteran-led recruitment team is partnering with a pharmaceutical company committed to helping, offering service members, veterans, and law enforcement professionals the opportunity to participate in a clinical research study evaluating a new treatment designed specifically for us.
WHO CAN JOIN?
To join you must
✓ Be 18-75 years of age
✔ Not be pregnant, planning to become pregnant, or breastfeeding
✓Have a prior diagnosis of major depressivedisorder(MDD)
✔Be currently taking antidepressants
Contact
To see if you’re eligible, contact
909-955-5865
https://bit.ly/iwantresearch
For more information about Ventura-5 research study at IPMG – Click Here
ITI Pediatric Bipolar 1 and 2 Depressive Episode
Are you interested in an investigational study drug for teenagers with bipolar depression? We are looking for study volunteers between 13 and 17 years of age who have been diagnosed with bipolar disorder and are currently experiencing a major depressive episode. To learn whether you, or someone you know, might be eligible, please visit our website to fill out our forms: Click Here
ALTO-100-211 Study
This study is intended to assess the safety and effectiveness of ALTO-100(an investigational medication), used adjunctively to an existing mood stabilizer
and/or one approved atypical antipsychotic.
The study will last approximately 3 to 4 months, consisting of a screening period
(about 6 weeks), followed by a 6-week double-blind treatment period where you may
receive ALTO-100 or placebo. If you complete the double-blind treatment period, you will
be given the option to enter a 7-week open-label period where you are guaranteed to
receive ALTO-100. Eligible participants will receive study-related care and evaluations at
no cost. Compensation for your time and travel may be available. To learn whether you, or someone you know, might be eligible, please visit our website to fill out our forms: Click Here
The Balance Study
- Are 10 to 17 years old
- Have a diagnosis of bipolar I disorder
- Are currently experiencing an episode of depression:
- Symptoms of depression include feeling sad, down, or depressed, not enjoying things you usually do, suicidal thoughts, difficulty falling or staying asleep, loss of energy, difficulty concentrating
Bipolar and Schizophrenia Study
A research study for children and teenagers with schizophrenia or Bipolar disorder.
This study is looking at how safe
a study drug is and how well it works in children and teenagers with schizophrenia or bipolar disorder.
The study drug is approved for the treatment of schizophrenia and bipolar depression in adults. However, it is not yet approved for children with schizophrenia or bipolar disorder.
The Balance Study will enroll about 338 children and teens with bipolar I depression at participating study centers throughout North America.
Does your child have schizophrenia or bipolar disorder? The 321 Study is looking for volunteers who are:
- 13-17 years of age with a diagnosis of schizophrenia
- 10-17 years of age with
a diagnosis of bipolar
I or II disorder (must have completed a prior lumateperone study).
BALSAM-3 Study
What is the BALSAM-3 Study?
The BALSAM-3 Study is a clinical study being done to learn more about the long-term safety and effectiveness of an
investigational drug called KarXT
in adults with bipolar disorder.
- Doctors and researchers want to see if KarXT can safely
manage symptoms and manic
episodes when taken for a long
period of time.
You may be considered for this
study if you:
- Are 18 to 65 years of age.
- Have bipolar-1 disorder.
- May be currently taking
lithium, valproate, or
lamotrigine
You can also call us (909) 955-5865 or email us at Research@inlandpsych.com
BALSAM-4 Study
What is the BALSAM-4 Study?
The BALSAM-4 Study is a clinical study testing an investigational
drug called KarXT in adults with
bipolar disorder.
- Doctors and researchers want to see if KarXT can safely manage symptoms and manic episodes when taken for a long period of time.
You may be considered for this
study if you:
- Are 18 to 65 years of age.
- Have bipolar-1 disorder.
- Are having a manic episode that requires them to be in an inpatient facility.
You can also call us (909) 955-5865 or email us at Research@inlandpsych.com
UPCOMING TRIALS
- Psychedelic Therapeutics
- Women’s Mental Health
- Generalized Anxiety Disorder
- Bipolar Disorder
- Schizophrenia
- Adolescent and Pediatric
- Dementia
Pediatric & Adolescent Clinical Trials
We are offering access to studies focused on discovering innovative methods for diagnosis, treatments, therapies and interventions for children with severe mental health symptoms or neurodevelopmental disorders.
Our dedicated team of researchers and physicians want to help kids with severe mental health symptoms such as Bipolar or Schizophrenia and Neurodevelopmental Disorders such as ASD and their families live happier, healthier lives.
Our Pediatric & Adolescent Research Suites are specifically designed to be a trusted place where children can feel safe and reach their true potential.
Research for children is needed to improve opportunities for those with Severe Mental Health Disorders and ASD-related neurodevelopmental issues.
At IPMG, we work with children & teens to collect firsthand data that helps us to better understand these conditions. With no two cases alike, the information gained from your child’s experience can support the development of life-changing treatments and therapies for your child and potentially for families worldwide.
It’s important for children and families to feel comfortable and safe while at their Clinical Research Visits which can include uncomfortable experiences like a blood draw.
Even adults often may find blood draws or lab draws to be anxiety provoking. We are so proud of our little ones that are brave enough to get routine blood draws and we want to ensure we provide the support needed during these visits.
Check your Child/Teens BMI
This is an important calculation needed to see if you or your child may be eligible for the particular Clinical trials.
